Exosome
CD31
Antibodies Panel
IR219-807 anti c-MET antibody WB image IR219-807 anti c-MET antibody WB image IR219-807 anti c-MET antibody WB image IR219-807 anti c-MET antibody WB image
+3
Catalog Number:IR219-807

c-MET antibody

Application
  • WB
  • IF
  • IHC
Reactivity Hu、Ms、Rat

REACTIVITYHu、Ms、Rat
SENSITIVITYEndogenous
MW130-170, p40 MET
SOURCERabbit-IgG

Product Includes

-

Application Dilution

Western Blot 1:500–1:1000
Immunofluorescence 1:100–1:200
Immunohistochemistry (Paraffin) 1:100

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C
100mM Tris Glycine, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative

Specificity / Sensitivity

Endogenous

Source / Immunogen

Synthetic peptide / encompassing a sequence within the C-terminus region.

This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]

Title
No data.

Reviews

Please login before enter the comment!